Form 4: NewAmsterdam Pharma Co N.V. Executive Granted 43,000 Restricted Stock Units

William A. Jones, Jr., Chief Commercial Officer of NewAmsterdam Pharma Co N.V., was granted 43,000 restricted stock units (RSUs) on January 7, 2025, which will vest over three years.

Summary

• William A. Jones, Jr., the Chief Commercial Officer of NewAmsterdam Pharma Co N.V., filed a Form 4 on January 7, 2025.
• The filing reports the grant of 43,000 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one ordinary share each.
• The RSUs vest in three equal installments on the first, second, and third anniversaries of the vesting start date, contingent upon continued service.

Sentiment

Score: 7

Explanation: The document indicates standard executive compensation practices, which is generally viewed neutrally to positively as it aligns management interests with shareholders.

Positives

• The grant of RSUs to the Chief Commercial Officer aligns his interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company's long-term success.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued service, suggesting an expectation of continued employment.

Industry Context

Granting RSUs to executives is a common practice in the pharmaceutical industry to incentivize performance and retain key personnel.

Comparison to Industry Standards

• Equity compensation packages for C-level executives in the pharmaceutical industry typically include a mix of salary, bonus, stock options, and restricted stock units.
• The specific terms of the RSU grant, such as the vesting schedule and the number of units granted, would need to be compared to industry benchmarks to assess its competitiveness.
• Companies like Amgen, Pfizer, and Johnson & Johnson also utilize similar equity compensation strategies for their executives.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the Chief Commercial Officer to drive company growth.
• Employees may see the RSU grant as a sign of the company's commitment to its leadership team.

Key Dates